Now you see me: lights on Merkel Cell Carcinoma.
Cristiano PiniCristiano PiniFabrizia GelardiLidija AntunovicPublished in: European journal of hybrid imaging (2023)
Merkel Cell Carcinoma (MCC) is a rare primary cutaneous cancer with aggressive behaviour and poor prognosis. Although MCC cells express somatostatin receptors (SSTR), SSTR-targeted PET/CT is not routinely performed in clinical practice. In contrast, the use of [ 18 F]FDG PET/CT is more widespread and its prognostic role is well established. We present the case of an MCC patient suspected recurrence who underwent restaging with both [ 18 F]FDG and [ 68 Ga]Ga-DOTA-TOC PET/CT. [ 18 F]FDG PET/CT showed pathological uptake only in mediastinal lymph nodes, but SSTR imaging also revealed multiple liver and skeletal metastases, leading to significant disease upstaging and relevant changes in the therapeutic management.
Keyphrases
- pet ct
- poor prognosis
- lymph node
- long non coding rna
- clinical practice
- induced apoptosis
- positron emission tomography
- papillary thyroid
- cell cycle arrest
- high resolution
- sentinel lymph node
- case report
- neoadjuvant chemotherapy
- pulmonary embolism
- magnetic resonance
- squamous cell carcinoma
- endoplasmic reticulum stress
- free survival
- signaling pathway
- cell death
- oxidative stress
- early stage
- ultrasound guided
- young adults
- mass spectrometry
- fluorescence imaging
- neuroendocrine tumors
- cell proliferation
- photodynamic therapy